Biographical Sketch
Mark Froimson, MD, MBA is the Quality Review Officer for the Orthopaedic and Rheumatologic Institute, charged with initiating and monitoring quality improvement efforts for the entire institute. He joined the Section of Adult Reconstruction Surgery in 1999, after serving as Director of Joint Reconstruction at another Cleveland academic center. He specializes in the surgical care of the hip and knee, with particular emphasis on primary and revision joint replacement and arthroscopy. Dr. Froimson accepts new patients with hip and knee problems. He conducts a clinic at the Main Cleveland Clinic Campus as well as at the Beachwood Family Health Center.
Dr. Froimson's research interests include evaluation of outcomes of joint replacement with particular emphasis on reducing complications. He has studied implant fixation, minimally invasive surgery, hip arthroscopy, partial joint resurfacing, alternative bearing surfaces, mobile bearing knee replacement and avascular necrosis of the hip. He is active in the education of orthopaedic residents, fellows and medical students, and lectures nationally and internationally on advances in hip and knee replacement.
Dr. Froimson was awarded membership into the Alpha Omega Alpha Medical Honor Society, received the Frank E. Stinchfield Award for Excellence in Orthopaedic Research and has been named to the list of Best Doctors numerous times. He was awarded a traveling fellowship from the Mid-America Orthopaedic Society, which he used to study the indications and effectiveness of arthroscopy of the hip.
He currently serves as President of the Cleveland Orthopaedic Society and is Executive Vice Chair of the Board of Trustees for the Northeastern Ohio Chapter of the Arthritis Foundation. He is a member of the American Academy of Orthopaedic Surgery, the American Orthopaedic Association, the Orthopaedic Research Society, the American Association of Hip and Knee Surgeons and numerous other national and international societies.
Specialty Interests
adult reconstruction, arthritis surgery, arthroplasty and fracture reconstruction, Avascular Necrosis, hip and knee replacement, hip and knee surgery, hip and knee total joint replacement revisions and infections, Hip joint replacement, including complex primary and revision hip and knee arthroplasty, joint aspiration and therapeutic injections, joint problems, Joint Replacement, joint replacement and reconstruction, joint replacement of the hip and knee, joint replacement surgery of the hip and knee, knee cartilage injuries, knee cartilage injury, knee joint disorders, Knee joint replacement, knee ligament injuries, knee ligament injury, knee surgery, primary and revision hip and knee replacements, primary and revision joint replacements, primary and revision total hip arthroplasty, primary and revision total knee arthroplasty, primary knee replacement, Reconstructive surgery of the hip and knee, reconstructive surgery of the hip and knee joints including arthroscopy, revision joint replacement, Revision knee joint replacement, revision knee replacement, Revision hip joint replacement, total hip and total knee replacement, total joint replacement, total joint replacement (hip and knee), Treatment Of Fracture Non-union, treatment of hip
Innovations & Patents
Product and surgical technique development -- Corail Total Hip System
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/4/2008, Dr.
Froimson has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Froimson receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
DePuy Orthopaedics, Inc.
Royalty Payments. Dr. Froimson has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
DePuy Orthopaedics, Inc.
